Lilly Medical US’ Post

View organization page for Lilly Medical US, graphic

19,830 followers

Approximately 30% of patients with high-risk, HR+, HER2- #EarlyBreastCancer experience disease recurrence within 5 years, often with distant metastases. Recognizing factors associated with a higher risk for recurrence is important for optimizing #AdjuvantTherapy. Learn more about high-risk features: https://e.lilly/3UuXUdV #BreastCancer #BCSM #Oncology #CancerCare

To view or add a comment, sign in

Explore topics